Synthetic methylotrophy is an innovative approach that enables microbes to use methanol—a low-cost, non-food carbon source—for the production of fuels, chemicals, and pharmaceuticals. By engineering well-known microorganisms, such as Escherichia coli and Corynebacterium glutamicum, to utilize methanol through the ribulose monophosphate (RuMP) cycle, researchers have significantly improved methanol incorporation into central metabolites. Adaptive Laboratory Evolution (ALE) has further optimized these strains, enhancing their ability to grow and tolerate methanol. This advancement opens up new opportunities for sustainable bio-manufacturing, reducing dependence on sugar-based feedstocks and offering an environmentally friendly alternative. As research continues, the integration of gene editing and metabolic control will drive the development of robust, high-performance methylotrophic platforms, making methanol a key feedstock for a circular, carbon-neutral bio-economy.